Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 410 participants.

Also called NCT07698223

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 410 participants (planned count) (from the registry)
Sponsor
Chen Xiangmei (from the registry)
Registry
  • NCT NCT07698223
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07698223. Randomized; double masking; primary purpose treatment. Start 2027-03-01 (anticipated); primary completion 2028-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD
Acronym
NXT-DKD
Condition
Diabetic Nephropathy
Intervention (Drug)
Naoxintong Capsule
Intervention (Drug)
Placebo
Lead sponsor
Chen Xiangmei (class: other)

Record details

Record id
cardio:ct-nct07698223
Content hash
6949eb6533f27ab275a9337bab7774a5decacb3ceb16cc5a37798b9d894d32ef